This HTML5 document contains 46 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n16http://linked.opendata.cz/resource/drugbank/drug/DB01483/identifier/pubchem-substance/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n5http://linked.opendata.cz/resource/drugbank/drug/DB01483/identifier/drugbank/
n13http://bio2rdf.org/drugbank:
n8http://linked.opendata.cz/resource/drugbank/drug/DB01483/identifier/chemspider/
n7http://linked.opendata.cz/resource/drugbank/drug/DB01483/identifier/chebi/
admshttp://www.w3.org/ns/adms#
n15http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n14http://linked.opendata.cz/resource/drugbank/drug/DB01483/identifier/wikipedia/
owlhttp://www.w3.org/2002/07/owl#
n9http://linked.opendata.cz/ontology/drugbank/
n17http://linked.opendata.cz/resource/drugbank/drug/DB01483/identifier/pharmgkb/
n10http://linked.opendata.cz/resource/drugbank/property/
n6http://linked.opendata.cz/resource/drugbank/drug/DB01483/identifier/kegg-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n4http://linked.opendata.cz/resource/drugbank/drug/DB01483/identifier/pubchem-compound/

Statements

Subject Item
n2:DB01483
rdf:type
n9:Drug
n9:description
A long-acting barbiturate that depresses most metabolic processes at high doses. It is used as a hypnotic and sedative and may induce dependence. Barbital is also used in veterinary practice for central nervous system depression. Barbital is a schedule IV controlled drug.
n9:group
illicit
owl:sameAs
n13:DB01483 n15:DB01483
dcterms:title
Barbital
adms:identifier
n4:2294 n5:DB01483 n6:C02517 n7:31252 n8:2206 n14:Barbital n16:46508979 n17:PA448538
n9:IUPAC-Name
n10:271B4ED0-363D-11E5-9242-09173F13E4C5
n9:InChI
n10:271B4ED6-363D-11E5-9242-09173F13E4C5
n9:Molecular-Formula
n10:271B4ED5-363D-11E5-9242-09173F13E4C5
n9:Molecular-Weight
n10:271B4ED2-363D-11E5-9242-09173F13E4C5
n9:Monoisotopic-Weight
n10:271B4ED3-363D-11E5-9242-09173F13E4C5
n9:SMILES
n10:271B4ED4-363D-11E5-9242-09173F13E4C5
n9:Water-Solubility
n10:271B4ECE-363D-11E5-9242-09173F13E4C5 n10:271B4EE5-363D-11E5-9242-09173F13E4C5
n9:logP
n10:271B4ECF-363D-11E5-9242-09173F13E4C5 n10:271B4ECC-363D-11E5-9242-09173F13E4C5 n10:271B4EE8-363D-11E5-9242-09173F13E4C5
n9:logS
n10:271B4ECD-363D-11E5-9242-09173F13E4C5 n10:271B4EE9-363D-11E5-9242-09173F13E4C5
n9:pKa
n10:271B4EEA-363D-11E5-9242-09173F13E4C5
n9:H-Bond-Acceptor-Count
n10:271B4EDC-363D-11E5-9242-09173F13E4C5
n9:H-Bond-Donor-Count
n10:271B4EDD-363D-11E5-9242-09173F13E4C5
n9:InChIKey
n10:271B4ED7-363D-11E5-9242-09173F13E4C5
n9:Polar-Surface-Area--PSA-
n10:271B4ED8-363D-11E5-9242-09173F13E4C5
n9:Polarizability
n10:271B4EDA-363D-11E5-9242-09173F13E4C5
n9:Refractivity
n10:271B4ED9-363D-11E5-9242-09173F13E4C5
n9:Rotatable-Bond-Count
n10:271B4EDB-363D-11E5-9242-09173F13E4C5
n9:casRegistryNumber
57-44-3
n9:Bioavailability
n10:271B4EE1-363D-11E5-9242-09173F13E4C5
n9:Boiling-Point
n10:271B4EE7-363D-11E5-9242-09173F13E4C5
n9:Ghose-Filter
n10:271B4EE3-363D-11E5-9242-09173F13E4C5
n9:MDDR-Like-Rule
n10:271B4EE4-363D-11E5-9242-09173F13E4C5
n9:Melting-Point
n10:271B4EE6-363D-11E5-9242-09173F13E4C5
n9:Number-of-Rings
n10:271B4EE0-363D-11E5-9242-09173F13E4C5
n9:Physiological-Charge
n10:271B4EDF-363D-11E5-9242-09173F13E4C5
n9:Rule-of-Five
n10:271B4EE2-363D-11E5-9242-09173F13E4C5
n9:Traditional-IUPAC-Name
n10:271B4ED1-363D-11E5-9242-09173F13E4C5
n9:pKa--strongest-acidic-
n10:271B4EDE-363D-11E5-9242-09173F13E4C5